SG Americas Securities LLC Sells 68,047 Shares of Tenet Healthcare Corporation $THC

SG Americas Securities LLC decreased its stake in Tenet Healthcare Corporation (NYSE:THC) by 36.7% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 117,161 shares of the company’s stock after selling 68,047 shares during the period. SG Americas Securities LLC’s holdings in Tenet Healthcare were worth $22,109,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of THC. Triumph Capital Management bought a new stake in shares of Tenet Healthcare in the 3rd quarter worth approximately $25,000. Activest Wealth Management bought a new position in Tenet Healthcare during the fourth quarter valued at $26,000. Elyxium Wealth LLC bought a new stake in shares of Tenet Healthcare in the fourth quarter valued at $29,000. Canada Pension Plan Investment Board purchased a new position in shares of Tenet Healthcare during the 2nd quarter valued at $35,000. Finally, Meeder Asset Management Inc. grew its stake in shares of Tenet Healthcare by 146.2% during the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after acquiring an additional 114 shares during the period. 95.44% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages recently issued reports on THC. Barclays lowered their price objective on Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 5th. TD Cowen lowered their price target on shares of Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating on the stock in a research report on Monday. Guggenheim cut their price objective on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating for the company in a report on Friday, May 1st. Royal Bank Of Canada reduced their price objective on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research note on Friday, May 1st. Finally, Morgan Stanley set a $254.00 target price on Tenet Healthcare in a research report on Friday, May 1st. Eighteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $244.32.

Insider Buying and Selling at Tenet Healthcare

In related news, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the sale, the director owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Nadja West sold 3,000 shares of the company’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the transaction, the director owned 24,805 shares in the company, valued at $4,399,166.75. This represents a 10.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.97% of the stock is currently owned by company insiders.

Tenet Healthcare Price Performance

THC stock opened at $183.48 on Thursday. The firm has a 50 day moving average of $181.50 and a 200-day moving average of $197.76. The firm has a market capitalization of $15.80 billion, a P/E ratio of 9.54, a price-to-earnings-growth ratio of 1.49 and a beta of 1.28. Tenet Healthcare Corporation has a 12 month low of $146.60 and a 12 month high of $247.21. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.39 billion. During the same period in the prior year, the company posted $4.36 EPS. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, sell-side analysts predict that Tenet Healthcare Corporation will post 17.61 earnings per share for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.